nasal_vaccine_1_1024x600

27
Dec

|
Reading Time: 40 seconds
|
by Admin
0
0
378
0

World’s First Nasal Vaccine Developed in India, Approved as a Booster Dose

The Central Drugs Standard Control Organization (CDSCO) has given the first intra-nasal COVID vaccine in the world approval for restricted use in life-threatening conditions in people age 18 and older.

The Union Health Ministry has approved Bharat Biotech's intranasal Covid vaccination as a booster dose for those 18 years of age and older and introduced it on the Co-WIN platform. Adults who have had two doses of either Covishield or Covaxin may receive a precautionary dosage of the needle-free vaccination, which is now accessible at private hospitals.

December 27, 2022
0
0
378
0

CATEGORIES

HIGHLIGHTS

Popular Tags

CheckBrand is the only platform to track your digital ranking, digital presence, and social media presence along with detailed analytics reports by which you can measure all the parameters of a digital domain.